January 16, 2012 – 12:09 pm
According to a new report published by Transparency Market Research (www.transparencymarketresearch.com) “Weight Management Market by Services, Supplements, Diet, Equipment and Devices: Global Analysis And Forecast (2007 – 2015)”Global Weight Management Market is estimated to be USD 385.1 billion in 2010 and expected to reach USD 650.9 billion in 2015 at a CAGR of 9.4% over [...]
January 6, 2012 – 10:59 am
Pharmacy Retail Market – India Description The pharmacy retail market is valued at INR 216 bn in 2009 and estimated to reach INR 432 bn in 2011. The market is fragmented and dominated by the unorganized sector. The report provides a snapshot of the pharmacy retail market. Market overview gives a quick picture of the [...]
January 6, 2012 – 10:19 am
Clinical Trials Market – India Description India is fast emerging as the most preferred destination for clinical trials. Clinical trial is the final step in drug development process after preliminary laboratory research and animal testing. The process of drug discovery is quite long and expensive and trials for any drug are usually conducted in phases [...]
January 5, 2012 – 11:59 am
United States Pharmaceutical Sector Report (2011 Edition) United States Pharmaceutical Sector Market United States is worlds largest spender on healthcare at an estimated 16% of GDP in 2010. This spending is likely to continue to grow at a faster pace in the light of healthcare reforms of 2010 that extended insurance to around 45.7 million residents. [...]
January 4, 2012 – 7:17 am
China Medicine Production Equipment Market Report China Medicine Production Equipment Market This report presents a clear picture about the overall development of medicine production equipment market in China and the trend in recent years based on detailed data analysis. This report includes the analysis on the medicine production equipment market size and market share in [...]
January 4, 2012 – 7:07 am
China Pollution Treatment Medical Materials Market Report China Pollution Treatment Medical Materials Market market share in China, the study on major hot areas in this market, introduction of key data and the comparison of top 10 enterprises in terms of sales revenue and market share, the detailed description of the import and export This report [...]
January 3, 2012 – 12:25 pm
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking, or lack of concentration and motivation and it is accompanied by significant social [...]
January 3, 2012 – 12:19 pm
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis Alzheimer’s Disease Patients Market Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant [...]
January 3, 2012 – 12:09 pm
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast World Vaccines Market For decades vaccines were a neglected corner of the drugs business, with old technology, little investment and abysmal profit margins. Many firms sold their vaccine divisions to concentrate on more profitable drugs. This troubled public-health experts because vaccines are a highly [...]
January 3, 2012 – 11:49 am
Single Cell Analysis 2010: the New Frontier for ‘Omics Market Report Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, [...]
January 3, 2012 – 11:45 am
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012 Circulating Tumor Cells and Cancer Stem Cells Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we focus upon the biology of CTCs and [...]
January 3, 2012 – 11:44 am
MicroRNA Market Trends 2011 MicroRNA Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketplace from [...]
January 3, 2012 – 11:42 am
Circulating Tumor Cells (CTCs)Market Trends 2011 Circulating Tumor Cells Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance [...]
January 3, 2012 – 11:41 am
Umbilical Cord Blood Banking Market Trends 2011 Umbilical Cord Blood Banking Market This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, [...]
January 3, 2012 – 11:39 am
Single Cell Omics 2011 Single Cell Omics Market The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers [...]
January 3, 2012 – 11:37 am
Adult Stem Cells Market Trends 2011 Adult Stem Cells Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics. [...]
January 3, 2012 – 11:35 am
Epigenetics Market Trends 2011 Epigenetics Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers. This report presents the biological role of various epigenetic [...]
January 3, 2012 – 11:33 am
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the [...]
January 3, 2012 – 11:32 am
Multiplexed Diagnostics 2010 Market Report Multiplexed Diagnostics Market The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. Will the FDA finally release the updated IVDMIA guidelines? If so, will the FDA close the CLIA loophole and/or will the FDA require [...]
January 3, 2012 – 11:31 am
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine Stem Cells Market This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem [...]
January 3, 2012 – 11:27 am
Adult Stem Cells and iPSCs 2010 Market Report Adult Stem Cells and iPSCs Market This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and [...]
January 3, 2012 – 11:21 am
Stem Cells for Cellular Therapy 2010 Market Report Stem Cells for Cellular Therapy Market This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stem cells space is broad and comprehensive—each segment of the space is therefore analyzed and presented in detail [...]
January 3, 2012 – 11:20 am
MicroRNA Research and Disease Associations 2010 Market Report MicroRNA and Disease Market This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends—both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of different [...]
January 2, 2012 – 1:14 pm
Optimizing Treatment for Bone Metastases in Patients with Advanced Cancers Understand current practice patterns related to bone metastases in patients with advanced cancers. Patient specific unfolding case scenarios presented to 174 high-prescribing oncologists on the treatment of bones metastases in patients with advanced stages of cancer including breast, renal cell carcinoma, and prostate. The survey [...]
January 2, 2012 – 1:13 pm
US Oncologist Survey: Optimizing Treatment for Advanced Non-Hodgkin’s Lymphoma Experience real patient situations that progressively unfold, presented to a representative sample of 158 US oncologists who manage 11 or more patients monthly with non-Hodgkin’s lymphoma. Oncologists were presented with four patient case scenarios and asked to respond to open-ended questions concerning their choices of treatment [...]
January 2, 2012 – 1:12 pm
US Oncologist Survey: Optimizing Treatment for Stage IV Follicular B-Cell Non-Hodgkin’s Lymphoma A patient specific case scenario on advanced non-Hodgkin’s lymphoma involving a patient with stage IV follicular B-cell that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal: Decisions in treatment and tests through [...]
January 2, 2012 – 1:10 pm
US Oncologist Survey: Optimizing Treatment for Large Cell Lymphoma Two patient specific case scenarios on advanced non-Hodgkin’s lymphoma involving patients with a) relapsed large cell lymphoma and b) large cell lymphoma with compromised cardiac function that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal: [...]
January 2, 2012 – 1:09 pm
US Oncologist Survey: Optimizing Treatment for Stage IIIA Asymptomatic Indolent Lymphoma Patient specific case scenario on advanced non-Hodgkin’s lymphoma in a situation involving a patient with Stage IIIA Asymptomatic Indolent Lymphoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals: Decisions in treatment and [...]
January 2, 2012 – 1:08 pm
US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer Experience real patient situations that progressively unfold, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of [...]
January 2, 2012 – 1:06 pm
Advanced Lung Cancer in Patient Light Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists’ Survey A patient specific case scenario on advanced lung cancer in a situation involving a patient that is a light smoker with lung adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on [...]
January 2, 2012 – 1:05 pm
Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma: Clinical Insights from a US Oncologists’ Survey A patient specific case scenario on advanced lung cancer in a situation involving a patient with EGFR Mutation Positive Adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals: [...]
January 2, 2012 – 1:04 pm
Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists’ Survey A patient specific case scenario on advanced lung cancer in a situation involving a smoker with squamous cell that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals: Decisions [...]
January 2, 2012 – 1:03 pm
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists’ Survey Castration Resistant Prostate Cancer Market Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors that influence their decisions, barriers to optimal treatment and confidence [...]
January 2, 2012 – 1:01 pm
US Oncologist Survey: Optimizing Treatment for Advanced Prostate Cancer Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients. [...]
January 2, 2012 – 12:59 pm
Advanced Prostate Cancer with Increased PSA and Adenocarcinoma: Clinical Insights from a US Oncologists’ Survey Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors that influence their decisions, barriers to optimal treatment and confidence [...]
January 2, 2012 – 12:58 pm
US Oncologist Survey: Optimizing Treatment for Advanced Renal Cell Cancer US Oncologist Survey Markets Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is [...]
January 2, 2012 – 12:55 pm
US Oncologist Survey: Optimizing Treatment for Metastatic Breast Cancer Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening at the patient [...]
January 2, 2012 – 12:52 pm
US Oncologist Survey: Optimizing Treatments for ER/PR Positive HER2/neu Negative Metastatic Breast Cancer Patient specific case scenarios that unfold throughout the report, presented to 174 high-prescribing oncologists on ER/PR Positive HER2neu Negative Metastatic Breast Cancer for their open responses on clinical decisions, distributed and collected December 15, 2010 and January 10, 2011. Patient progression reveals [...]
January 2, 2012 – 12:43 pm
Triple Negative Metastatic Breast Cancer: Clinical Insights from a US Oncologists Survey Triple Negative Metastatic Breast Cancer Market Primary research that presents a patient specific case scenario unfolding throughout the report, to 174 high-prescribing oncologists on Triple Negative Metastatic Breast Cancer for their open responses on specific clinical decisions. Patient progression reveals: Decisions in treatment throughout [...]